ResMed-sponsored Studies Show Combining Home Oxygen and Home Non-invasive Ventilation is a Cost Effective Treatment for COPD
ResMed (NYSE: RMD, ASX: RMD) announced today the results of two clinical analyses conducted for the U.K. and U.S., demonstrating the cost effectiveness of combining home oxygen therapy and home non-invasive ventilation (NIV) therapy for patients with persistent hypercapnia following a life-threatening exacerbation of chronic obstructive pulmonary disease (COPD).
The ResMed-backed Home Oxygen Therapy – Home Mechanical Ventilation (HOT-HMV) health economic studies, presented today at the ATS 2018 International Conference, build on earlier data demonstrating the clinical and cost effectiveness of HOT-HMV therapy (i.e. combining home oxygen therapy with home NIV), compared to treating with oxygen alone.
The U.K. study found that HOT-HMV treatment reduced exacerbation frequency and 28-day hospital readmission. The U.S. analysis found a 58.3 percent reduction in 30-day readmissions for HOT-HMV patients compared to those on home oxygen alone – and that HOT-HMV can actually save patients money while improving their quality of life.
“It’s common for a procedure or therapy to improve patient outcomes and quality of life, but it’s rare to have a significant clinical impact with such a favorable economic impact as well, as HOT-HMV does,” said ResMed Chief Medical Officer Carlos M. Nunez, M.D. “This finding is very positive news for people living with COPD who could benefit from HOT-HMV. The cost-saving potential is one more factor for encouraging wider use of this therapy option.”
About the analyses
Cost-Effectiveness of Home Oxygen Therapy – Home Mechanical Ventilation (HOT-HMV) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) with Chronic Hypercapnic Respiratory Failure Following an Acute Exacerbation of COPD in the United Kingdom (UK): This economic analysis was based on patient-level medical resource utilization (MRU) from the intention-to-treat analysis of an open-label parallel-group randomized clinical trial. Patients with a hospital admission due to an exacerbation of COPD requiring acute home mechanical ventilation (also known as non-invasive ventilation, or NIV) with persistent hypercapnia 2–4 weeks after resolution of respiratory acidosis were enrolled. Patients in the control arm were permitted to have NIV added to home oxygen therapy if the primary end-point (hospital readmission) was met and if pre-set safety criteria were breached (for example, persistent acidosis and inability to wean from NIV). The MRU analysis included patient-level evaluation of equipment (oxygen concentrator and NIV device, including maintenance and support), patient-reported medication, physician office visits, and hospital readmissions due to exacerbations. Trial data was used to develop an economic model from the U.K. National Health Service perspective. Costs were calculated by multiplying observed MRU by standard unit costs (2017£) and summed at the patient level. Quality-adjusted life years (QALYs) were measured based on patient health utilities calculated with U.K. coefficients and EuroQOL-5D data from the trial. One-way sensitivity analyses and a bootstrap analysis with 1,000 iterations were conducted.
The U.S. analysis was based on the U.K. study. Trial data was used to develop an economic model from the U.S. payer perspective. Costs were calculated by multiplying observed MRU by standard unit costs (2017$) and summed at the patient level. QALYs were measured based on patient health utilities calculated with U.S. coefficients and EuroQOL-5D data from the trial. One-way sensitivity analyses and a bootstrap analysis with 1,000 iterations were conducted. Base-case incremental cost/QALYs gained was negative $50,856.
ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 5 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Saudi Arabia’s Red Sea Project on Track13.12.2018 13:49 | Pressemelding
A delegation from the Red Sea Development Company, led by chief executive John Pagano, was received by King Salman bin Abdulaziz at Araqa Palace in Riyadh on Tuesday (December 11). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005406/en/ King Salman bin Abdulaziz of Saudi Arabia (centre) and Crown Prince Mohammed bin Salman with John Pagano, CEO of Red Sea Development Company. [Photo courtesy Saudi Press Agency (SPA)] Mr. Pagano made a visual presentation at the palace on the master plan of the Red Sea Project, underlining its economic and development goals and the project’s objective to become a global destination for luxury tourism. Crown Prince Mohammed bin Salman, Chairman of the company, was also present. Twenty-two islands on the Red Sea will be developed as part of the project that is expected to create an estimated 70,000 jobs. It will not just contribute SAR 22 billion to Saudi Arabia’s GDP, but play a major
GSMA’s Programme ‘Tech4Girls’ Wins 2018 Corporate Citizen of the Americas Award from the Organization of American States13.12.2018 13:00 | Pressemelding
The Trust for the Americas has selected GSMA as a winner of the 2018 Corporate Citizen of the Americas Award in the category ‘Technical Skills for the Future of Work’ for its program ‘Tech4Girls’. The award was presented by the Secretary General of the Organization of American States (OAS), Luis Almagro, at a ceremony held last week in Washington, D.C. Ana Tavares Lattibeaudiere, Head of North America, and Paula Ferrari, Regional Marketing Director for Latin America, received the award on behalf of the GSMA. Tech4Girls is part of the global GSMA’s Women4Tech programme, which focuses on reducing the persistent gender gap in the mobile industry. Women4Tech offers different touchpoints for women across their education and career journeys through dedicated initiatives, development and networking opportunities. Women4Tech supports the United Nations Sustainable Development Goals, in particular SDG 5: “Gender Equality.” Launched in March 2018 by GSMA North America, Tech4Girls delivers hands-
FLIR Systems Launches Three Cooled Neutrino Family Thermal Camera Cores13.12.2018 13:00 | Pressemelding
FLIR Systems, Inc. (NASDAQ: FLIR) today announced three Neutrino™ midwave infrared (MWIR) camera cores: the small, lightweight FLIR Neutrino LC and two FLIR Neutrino Performance series cores, the SX12 and QX. The latest models expand the FLIR Neutrino cooled camera core family for commercial, industrial, and defense original equipment manufacturers (OEM) and system integrators. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005036/en/ Next generation cooled FLIR Neutrino thermal camera cores: Neutrino LC (left) and Neutrino Performance Series (right). (Photo: Business Wire) The Neutrino LC is FLIR’s first High Operating Temperature (HOT) MWIR camera core and the first model in the SWaP+C (Size, Weight, Power, and Cost) series. As the smallest, lightest weight, and lowest power consuming Neutrino model available, the LC can be integrated with smaller drones and allow drone operators to fly longer. With HOT technology, N
TYAN Introduces Entry Server Platforms Optimized for the New Intel® Xeon® E-2100 Processors13.12.2018 13:00 | Pressemelding
TYAN®, an industry-leading server platform design manufacturer and a MiTAC Computing Technology Corporation subsidiary, is releasing a broad selection of new server motherboards and systems optimized for the new Intel® Xeon® E-2100 processors. The new lineup is designed to offer enhanced performance, advanced security, and reliability of cost-effective entry server solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005005/en/ TYAN's New Intel Xeon E-2100 Processor-based Platforms Increase Reliability and Security for Entry Servers. (Photo: Business Wire) “Small and medium-size businesses need to maintain their competitiveness by deploying a powerful server platform for performance, enhanced memory capabilities, and hardware-enhanced security,” said Danny Hsu, Vice President of MiTAC Computing Technology Corporation's TYAN Business Unit. “TYAN’s Intel® Xeon® E-2100 processor-based platforms are optimized for clou
Biomax Informatics launches the NeuroXM™ Brain Science Suite13.12.2018 12:57 | Pressemelding
Biomax Informatics AG announced the launch of its latest product, the NeuroXM™ Brain Science Suite, this week at the Biomax-ETRI Symposium on Cognitive Brain Informatics held in Planegg, Germany. Following a successful early-adaptor program, the company launched the NeuroXM suite of tools and features for working with multimodal high-dimensional brain data ready for clinical use. The award-winning NeuroXM Brain Science Suite lets brain scientists work interactively with high-dimensional multimodal brain data ranging from neuroimaging to genetics and transcriptomics. The suite includes a unified knowledge model for managing the abundant heterogeneous data available for the brain. It connects patient brain data to public knowledge in databases, atlases and ontologies for automatic annotation with methodological meta-information so that they become invaluable for clinical and scientific use. The NeuroXM suite supports every brain science task from standardizing preprocessing workflows to
Slice Insurance Cloud Services Now Available in the UK & EU13.12.2018 12:00 | Pressemelding
Slice Labs Inc., an award-winning on-demand insurance cloud platform provider, announced today the availability of Insurance Cloud Services (ICS) in the UK and EU. The first customer to use ICS in the UK is Legal & General with the launch of on-demand, pay-per-use homeshare cover. Insurance products available through the Slice ICS platform offer customers a rich, engaging, fully digital experience that is quick, and flexible. True to the company’s stated intention of extending global availability of ICS following a $20M USD Extended Series A, UK and EU insurers are now able to subscribe to ICS and launch on-demand insurance products customised to locale, language, and demographics. Cheryl Agius, CEO of Legal & General’s Insurance division, said “Legal & General is delighted to be working with Slice on the new on-demand product, a growing business in the US and now in the UK market.” European insurtech influencer Dr. Robin Kiera, CEO of DigitalScouting added, “Digital transformation lea